Maha Zafar
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Roswell Park Comprehensive Cancer Center (2026); Mercy Medical Center (2023–2025); Rawalpindi Medical University (2025); Columbia University Irving Medical Center (2021); John Peter Smith Hospital (2024); Lahore General Hospital (2025–2026); Smith Family (2024); Cooper Green Mercy Hospital (2023–2024); Mercy Clinic Neurology (2024); Mercy Hospital (2023–2025); Hospice Buffalo (2026); CHI Health Mercy Council Bluffs (2023–2025); Mayo Hospital (2021); Jacobs Institute (2026); Smith Clinic (2024); Mercy Hospital (2023–2025); Lebanese American University (2021); University at Buffalo, State University of New York (2026); Rogers (United States) (2024); Albany Medical Center Hospital (2021); University of Veterinary and Animal Sciences (2025–2026)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Maha Zafar's research interests encompass hematology-oncology, with a focus on cancer genetics and various types of malignancies. She has contributed to several publications examining treatment efficacy and safety. Recent work includes a meta-analysis on the use of intravenous iron in patients with iron deficiency and heart failure with reduced ejection fraction, and systematic reviews on tyrosine kinase inhibitors for immune thrombocytopenic purpura and gene therapy for hemophilia A.
Zafar's publications also explore the potential of phytochemicals for Parkinson's therapy and the impact of germline genetic mutations in breast cancer patients. She has also investigated genomic signatures in non-small cell lung cancer patients. Her scholarly contributions are reflected in an h-index of 3 and over 50 publications. She has collaborated with several researchers at the University of Arkansas – Fort Smith on shared publications.
Metrics
- h-index: 3
- Publications: 53
- Citations: 75
Selected Publications
-
Abstract PS3-05-18: Non-breast cancer related germline mutations in breast cancer patients: a single institution experience (2026)
-
Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis (2025)
-
AML-463: Unraveling a Unique Presentation of Cold Agglutinin Disease in Myeloid Malignancy (2025)
-
Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma (2025)
-
Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis (2025)
-
Impact of Early Testing and Analysis of Germline Genetic Mutation in Patients with Breast Cancer: A Single Institution Experience (2025)
-
PATH-61. GENOMIC SIGNATURE IN NON-SMALL CELL LUNG CANCER PATIENTS METASTATIC TO BRAIN-A SINGLE INSTITUTION EXPERIENCE (2024)
-
MM-218 A Unique Presentation of Solitary Extramedullary Plasmacytoma (2024)
-
Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review (2024)
-
MM-361 Central Nervous System Relapse of Multiple Myeloma: A Case Report (2024)
-
MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review (2024)
-
TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis (2023)
-
TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis (2023)
-
Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials (2023)
Collaboration Network
Top Collaborators
- Safety and Efficacy of Tyrosine Kinase Inhibitors in Immune Thrombocytopenic Purpura: A Systematic Review of Clinical Trials
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- PATH-61. GENOMIC SIGNATURE IN NON-SMALL CELL LUNG CANCER PATIENTS METASTATIC TO BRAIN-A SINGLE INSTITUTION EXPERIENCE
- Impact of Early Testing and Analysis of Germline Genetic Mutation in Patients with Breast Cancer: A Single Institution Experience
- Late Onset Malignant Metastatic Transformation of Benign Pheochromocytoma
- AML-463: Unraveling a Unique Presentation of Cold Agglutinin Disease in Myeloid Malignancy
- TCT-691 Efficacy and Safety of Interatrial Shunts in Chronic Heart Failure Patients: An Updated Meta-Analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- TCT-726 Efficacy of Renal Denervation and Antihypertensives in Patients With Resistant Hypertension: A Systematic Review and Network Meta Analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- Efficacy of renal denervation with and without antihypertensives in patients with resistant hypertension: A systematic review and meta-analysis
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- MCL-430 Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
- Efficacy of Orelabrutinib in Mantle Cell Lymphoma: A Systematic Review
Similar Researchers
Based on overlapping research topics